NEW YORK (GenomeWeb) – A new study suggests miscarriage rates may not drop significantly when cell-free DNA screening is incorporated into the trisomy 21 testing protocol for women with "high risk" pregnancies.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Feb
26
Sponsored by
Advanced Cell Diagnostics

This webinar will demonstrate how a research team at the Firestone Institute for Respiratory Health at McMaster University developed a cellular and molecular phenotyping pipeline using archived samples of lung tissue derived from patients diagnosed with fibrotic interstitial lung disease.